ArticleBMC cancer2026
Awareness and acceptability of HPV vaccination among parents of young girls in northern Morocco: a mixed-methods study.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMorocco implemented a national HPV vaccination program in 2022 as part of its primary cervical cancer prevention strategy. The program faces several challenges, with very low vaccination coverage, likely due to parental hesitancy. This study aimed to assess the acceptability of HPV vaccination among parents of young girls.
methodsA mixed-methods study was conducted between 2024 and 2025 among parents of young girls in northern Morocco. We combined quantitative method with face-to-face questionnaire, analyzed using descriptive, univariate and multivariate statistics; and qualitative data from a focus group analyzed thematically.
resultsA total of 300 parents were recruited, with a mean age of 37.96 ± 8.0 years and a sex ratio F/M of 2.33. Only 10% of participants knew that cervical cancer is caused by persistent HPV infection. Awareness of the national HPV vaccination program was low (8.7%). Overall, 60% of parents reported good acceptability of HPV vaccination. Older age and formal education were independently associated with HPV vaccination hesitancy (OR = 1.046; 95% CI: (1.013-1.081; p < 0.006 and OR = 2.404; 95% CI: 1.334-4.331; p < 0.004). Qualitative findings indicated excellent acceptability of HPV vaccination, with lack of uptake primarily due to insufficient awareness of the disease, its vaccine, and the Moroccan HPV vaccination program.
conclusionOur study found no evidence of an association between the low HPV vaccination rate in Morocco and parental acceptability. Nevertheless, limited awareness of the national HPV vaccination program remains a major concern. Barriers to HPV vaccination should be further explored through implementation research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.